Clinical Trial Update: Immune Effects of Vitamin D in Hemodialysis Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the immune effects of vitamin D in patients with end-stage renal disease undergoing hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• End-stage Renal Disease

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Renal Research Institute | Conditions: End Stage Renal Disease, Hemodialysis | Phase 2 | Status: COMPLETED